Search results for "Small"

showing 10 items of 2441 documents

The "spoke wheel" sign in mesenteric carcinoid.

2019

medicine.medical_specialtyUrologyMEDLINEContrast MediaCarcinoid TumorMetastasiDiagnosis DifferentialText miningX ray computedInternal medicineIntestinal NeoplasmsIntestine SmallmedicineHumansRadiology Nuclear Medicine and imagingMesenteryPeritoneal NeoplasmsRadiological and Ultrasound Technologybusiness.industryGastroenterologyHepatologySmall bowelRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaTomography X-Ray ComputedCTAbdominal radiology (New York)
researchProduct

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy

2004

LDL can be subfractionated into buoyant (1.020-1.029 g/ml(-1)), intermediate (1.030-1.040 g/ml(-1)), and dense (1.041-1.066 g/ml(-1)) LDLs. We studied the rebound of these LDL-subfractions after LDL apheresis in seven patients with heterozygous familial hypercholesterolemia (FH) regularly treated by apheresis (58 +/- 9 years, LDL-cholesterol = 342 +/- 87 mg/dl(-1), triglycerides = 109 +/- 39 mg/dl(-1)) and high-dose statins. Apolipoprotein B (apoB) concentrations were measured in LDL subfractions immediately after and on days 1, 2, 3, 5, and 7 after apheresis. Compartmental models were developed to test three hypotheses: 1) that dense LDLs are derived from the delipidation of buoyant and in…

medicine.medical_specialtyVery low-density lipoproteinApolipoprotein Blow density lipoprotein metabolismFamilial hypercholesterolemiaQD415-436Biochemistrychemistry.chemical_compoundEndocrinologyInternal medicinerebound kineticsmedicinesmall dense low density lipoproteinsdensity gradient ultracentrifugationbiologyfamilial hypercholesterolemiaChemistryCholesterollow density lipoprotein subtypesCell BiologyMetabolismmedicine.diseaseEndocrinologyApheresisLDL apheresisbiology.proteinDensity gradient ultracentrifugationlipids (amino acids peptides and proteins)Journal of Lipid Research
researchProduct

A Systematic Review of Pharmacologic and Rehabilitative Treatment of Small Fiber Neuropathies

2020

The aim of this systematic review is to guide the physician in defining the pharmacologic and rehabilitative therapeutic approaches for adopting the best strategies described in the current literature. The search was conducted in PubMed, EMBASE, Cochrane Library and Web of Science to identify the treatment of small fiber neuropathies. Two reviewers independently reviewed and came to a consensus on which articles met inclusion/exclusion criteria. The authors excluded the duplicates, animal studies and included the English articles in which the treatment of patients with small fiber neuropathies was described. The search identified a total of 975 articles with the keywords “small fiber neurop…

medicine.medical_specialtyWeb of sciencesmall fiber neuropathymedicine.medical_treatmentClinical Biochemistrysystematic reviewsReviewCochrane LibraryPharmacological treatment03 medical and health sciences0302 clinical medicinemedicine030212 general & internal medicineSmall Fiber Neuropathysmall fiber neuropathy; treatment; systematic reviewsIntensive care medicineProtocol (science)lcsh:R5-920Rehabilitationtreatmentbusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaSystematic reviewRehabilitative treatmentlcsh:Medicine (General)business030217 neurology & neurosurgeryDiagnostics
researchProduct

An mHealth App for Supporting Quitters to Manage Cigarette Cravings With Short Bouts of Physical Activity: A Randomized Pilot Feasibility and Accepta…

2016

BackgroundWhile gains in reducing smoking rates in Finland have been made, prevalence rates are still substantial. Relapse rates among smokers engaged in quit-smoking programs are high. Physical activity has been proposed as one means to help smokers manage cravings. Software and apps on mobile phone and handheld devices offer an opportunity to communicate messages on how to use physical activity to manage cravings as part of quit-smoking programs. ObjectiveWe aimed to test the feasibility, acceptability, usability, and preliminary efficacy of an mHealth mobile phone app, Physical activity over Smoking (PhoS), to assist smokers in quitting smoking in a randomized controlled trial. The app w…

medicine.medical_specialtybehavior change020205 medical informaticsmedia_common.quotation_subjectphysical activityHealth Informatics02 engineering and technologyInformation technologyliikuntaRelapse preventionsmokinglaw.invention03 medical and health sciencesphysical training0302 clinical medicineRandomized controlled triallawtupakointikäyttäytymismallitIntervention (counseling)mental disorders0202 electrical engineering electronic engineering information engineeringmedicinemobiilisovellukset030212 general & internal medicineta315mHealthrelapse preventionmedia_commonmobile appsOriginal Paperbusiness.industrywithdrawalPublic healthBehavior changebehavioural patternsUsabilityta3141ta3142vieroitusAbstinenceT58.5-58.64mHealth appmHealthrandomized controlled trialPhysical therapyPublic aspects of medicineRA1-1270businessJMIR Mhealth Uhealth
researchProduct

Investigational agents for Crohn's disease.

2010

IMPORTANCE OF THE FIELD: Increased understanding of the biological mechanisms of Crohn's disease has opened the door to a large number of new molecules; some of these are approved for clinical use, while others remain under evaluation. In this review, we examine the clinical efficacy of all the new drugs that have been evaluated in controlled trials in the last 12 years. AREAS COVERED IN THIS REVIEW: Anti-TNF therapy has been reviewed briefly, given the many comprehensive reviews on this topic; attention is focused mainly on the other biological therapies. In assessing the clinical efficacy of these molecules, we consider only the remission rate, as this is considered the most meaningful en…

medicine.medical_specialtybiological therapy. Crohn' s disease. Integrins.Probiotics.Small molecules.DiseaseAdaptive ImmunityReceptors Tumor Necrosis FactorCrohn DiseaseGastrointestinal AgentsmedicineHumansImmunologic FactorsPharmacology (medical)Clinical efficacyIntensive care medicineRandomized Controlled Trials as TopicPharmacologyMitogen-Activated Protein Kinase KinasesBiological therapiesCrohn's diseaseEverolimusEnd pointINVESTIGATIONAL AGENTSbusiness.industryRemission InductionAntibodies MonoclonalGeneral MedicineDrugs Investigationalmedicine.diseaseImmunity InnateImmunologyCytokinesRemission rateImmunotherapybusinessCell Adhesion Moleculesmedicine.drugExpert opinion on investigational drugs
researchProduct

Analysis of gut microbiota in advanced non-small cell lung cancer (NSCLC) patients treated with immune-checkpoints blockers

2019

Abstract Background The microbiota community is considered as an organ of the human body. Recent studies have found that dysbiosis may have an impact on the interaction between immune regulation and tumor treatment. The main objective of this study is to characterize the gut microbiota in patients with non-small cell lung cancer (NSCLC) in advanced stages, and its relationship with obesity, smoking habits, clinical pathological features and response to treatment with immune-checkpoints blockers (ICB). Methods 16S rRNA gene sequencing was performed on 48 stool samples from advanced NSCLC patients prior to treatment with ICB (PD-1 inhibitor and PD-L1 inhibitor). The database used for the taxo…

medicine.medical_specialtybiologybusiness.industrynon-small cell lung cancer (NSCLC)HematologyDiseaseGut floramedicine.diseasebiology.organism_classificationGastroenterologyOncologyInternal medicinemedicinePrevotellaAdenocarcinomaMicrobiomebusinessAlistipesDysbiosisAnnals of Oncology
researchProduct

Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes

2011

Type 2 diabetes is associated with a cluster of inter-related plasma lipid and lipoprotein abnormalities, including reduced HDL-C, a predominance of small, dense LDL and elevated triglycerides. These abnormalities occur even in prediabetes, before blood sugars rise sufficiently in order to confirm a diagnosis of diabetes, and this transition phase incurs important cardiovascular risk. This is the rationale for paying attention to dyslipidemia through the use of the hypolipidemic, rather than hypoglycemic drugs only. A literature search (by Medline and Scopus) was performed. The authors also manually reviewed the references of selected articles for any pertinent material. Beyond the ‘quantit…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentType 2 diabetesmedicine.diseaseMetformindiabetes LDL size prevention small dense LDL therapyEndocrinologyInternal medicineDiabetes mellitusmedicinelipids (amino acids peptides and proteins)PrediabetesCardiology and Cardiovascular MedicinebusinessPioglitazoneDyslipidemiamedicine.drugLipoproteinClinical Lipidology
researchProduct

Reply: Sensory profile in primary restless legs syndrome and restless legs syndrome associated with small fibre neuropathy

2010

Sir, We wish to thank the editor for giving us the opportunity to respond to this letter. We appreciated reading that Drs Gemignani and Vitetta think our study (Bachmann et al. , 2010) provides support for the differential diagnosis of primary and secondary restless legs syndrome (RLS) associated with small fibre neuropathy, when comparing the sensory profiles of these groups of patients for the first time. Dr Gemignani recently wrote ‘A general consensus on the proposed criteria for the diagnosis of small fibre neuropathy has not been established’ (Gemignani, 2010 b ). This already applies for small fibre neuropathy without complicating RLS; however, for the constellation of RLS with small…

medicine.medical_specialtybusiness.industryShooting painSensory profilemedicine.diseaseComorbidity03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmental disordersSmall Fibre NeuropathymedicinePhysical therapyTingling030212 general & internal medicineNeurology (clinical)Restless legs syndromeDifferential diagnosisSecondary restless legs syndromebusiness030217 neurology & neurosurgeryBrain
researchProduct

Changes in natriuretic peptides and cytokines plasma levels in patients with heart failure, after high dose of furosemide plus small volume saline so…

2008

medicine.medical_specialtybusiness.industrySmall volumeFurosemidePlasma levelsmedicine.diseaseEndocrinologySaline solutionsInternal medicineAnesthesiaHeart failureInternal MedicinemedicineIn patientbusinessSaline loadingmedicine.drug
researchProduct

Urinary diversion and reconstruction.

2000

Orthotopic bladder augmentation and substitution has been established as the standard procedure for urinary diversion in many institutions, with current studies reporting mainly on continence rates and procedure-associated complications, such as the risk of impairment of neobladder function by local tumor recurrences in the small pelvis. Similarly, in other types of continent diversion, such as continent cutaneous diversion and rectal reservoirs, current interest is primarily directed towards minimization of surgery-associated complications.

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrinary diversionUrinary BladderUrinary Reservoirs ContinentUrinary Bladder Diseasesrespiratory systemPlastic Surgery ProceduresUrinary DiversionSmall pelvisStandard procedureSurgeryUrodynamicsPostoperative ComplicationsUrinary IncontinenceUreter surgeryBladder augmentationMedicineHumansUreterbusinesshuman activitiesCurrent opinion in urology
researchProduct